Minimizing fucosylation in insect cell‐derived glycoproteins reduces binding to IgE antibodies from the sera of patients with allergy
- 22 April 2014
- journal article
- research article
- Published by Wiley in Biotechnology Journal
- Vol. 9 (9) , 1206-1214
Abstract
The baculovirus/insect cell system has proven to be a very powerful tool for the expression of several therapeutics. Nevertheless, these products sometimes suffer from reduced biological activity and unwanted side effects. Several studies have demonstrated that glycosylation can greatly influence the structure, function, half‐life, antigenicity and immunogenicity of various glycoproteins. Yet, the glycosylation pattern of insect cell‐derived products is not favorable for many applications. Especially, the presence of core α1,3‐linked fucose bears the risk of causing immediate hypersensitivity reactions in patients with allergy. In this study, we evaluated the impact of fucose residues on the allergenic potential of an insect cell‐expressed vaccine candidate. In order to block the GDP‐L‐fucose de novo synthesis pathway, we integrated the Pseudomonas aeruginosa GDP‐6‐deoxy‐D‐lyxo‐4‐hexulose reductase (RMD) gene into a baculovirus backbone. This virus was then used for the expression of soluble influenza A virus hemagglutinin (HA). Expression studies showed that the co‐expression of RMD did not influence the overall level of recombinant protein secretion. We confirmed the result of our strategy by analyzing PNGase A‐released N‐glycans using MALDI‐TOF‐MS. In order to evaluate the biological impact of defucosylation of influenza HA we tested the binding activity of IgE derived from the sera of patients with allergy to the purified antigen. The non‐fucosylated HA showed a 10‐fold decrease in IgE binding levels as compared to wildtype variants.same article under 10.1002/biot.201300061.Keywords
Funding Information
- Austrian Fonds zur Förderung der wissenschaftlichen Forschung (FWF) (P 25092-B13, F 4603)
This publication has 45 references indexed in Scilit:
- A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin SubstratesPLOS ONE, 2012
- SweetBac: A New Approach for the Production of Mammalianised Glycoproteins in Insect CellsPLOS ONE, 2012
- A new glycoengineered insect cell line with an inducibly mammalianized protein N-glycosylation pathwayGlycobiology, 2011
- Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trialVaccine, 2011
- New baculovirus expression tools for recombinant protein complex productionJournal of Structural Biology, 2010
- Allergenicity of Carbohydrates and Their Role in Anaphylactic EventsCurrent Allergy and Asthma Reports, 2009
- Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human bloodBMC Cancer, 2009
- An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial resultsVaccine, 2008
- A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteinsGlycobiology, 2003
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970